Journals / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 3

Adult Primary Antibody Deficiencies and the Lung

Pages
257–264
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early diagnosis and appropriate management of primary antibody deficiency diseases in patients with respiratorysymptoms are crucial to decrease complications and increase survival.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Primary antibody deficiency diseases result from a genetic defect that causes misfunction of 1 or more of the immune system elements.Due to the increased awareness among physicians and the success of new treatment modalities, the number of pediatric patients reaching adult age and the number of patients diagnosed in adult age is increasing.
📊
Key Findings & Data:Adult patients comprise more than half of the total cases.Primary antibody deficiencies are the most common immunodeficiency type in adults, and these may cause recurrent upper and lowerrespiratory tract infections and result in the development of bronchiectasis.
💡
Conclusion & Impact:Early diagnosis and appropriate management of primary antibody deficiency diseases in patients with respiratorysymptoms are crucial to decrease complications and increase survival.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Primary antibody deficiency diseases result from a genetic defect that causes misfunction of 1 or more of the immune system elements.Due to the increased awareness among physicians and the success of new treatment modalities, the number of pediatric patients reaching adult age and the number of patients diagnosed in adult age is increasing. Adult patients comprise more than half of the total cases.Primary antibody deficiencies are the most common immunodeficiency type in adults, and these may cause recurrent upper and lowerrespiratory tract infections and result in the development of bronchiectasis. Among non-infectious pulmonary complications, any type ofinterstitial lung disease may be seen; however, a special type seen in patients with common variable immunodeficiency, namely granulomatous lymphocytic interstitial lung disease, is the one most commonly investigated. Underlying or accompanying immunodeficiencymay be present in patients with asthma and chronic obstructive pulmonary disease, especially if the disease requires frequent hospitalizations and/or is severe. Early diagnosis and appropriate management of primary antibody deficiency diseases in patients with respiratorysymptoms are crucial to decrease complications and increase survival.

🔖

Cite This Article

ÇELEBİOĞLU, E. (2021). Adult Primary Antibody Deficiencies and the Lung. Turkish Thoracic Journal, Cilt: 22 - Sayı: 3, 257–264. https://ajindex.com/articles/414142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. van Zelm MC, Condino-Neto A, Barbouche MR. Editorial: Primary immunodeficiencies worldwide. Front Immunol. 2019
  2. 22(10):3148. [CrossRef] 2. Rosenberg E, Dent PB, Denburg JA. Primary immune deficiencies in the adult: A previously underrecognized common condition. J Allergy Clin Immunol Pract. 2016
  3. 4(6):1101-1107. [CrossRef] 3. Bousfiha AA, Jeddane L, Ailal F et al. Primary immunodeficiency diseases worldwide: More common than generally thought. J Clin Immunol. 2013
  4. 33(1):1-7. [CrossRef] 4. Edgar JD, Buckland M, Guzman D et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: Report of the first 4 years' activity 2008-2012. Clin Exp Immunol. 2014
  5. 175(1):68- 78. [CrossRef] 5. Baumann U, Routes JM, Soler-Palacín P, Jolles S. The lung in primary immunodeficiencies: New concepts in infection and inflammation. Front Immunol. 2018
  6. [CrossRef] 6. Pilette C, Ouadrhiri Y, Godding V, Vaerman JP, Sibille Y. Lung mucosal immunity: Immunoglobulin-A revisited. Eur Respir J. 2001
  7. 18(3):571-588. [CrossRef] 7. Chai Q, Lu Z, Liu CH. Host defense mechanisms against mycobacterium tuberculosis. Cell Mol Life Sci. 2020
  8. 77(10):1859- 1878. [CrossRef] 8. Invernizzi R, Lloyd CM, Molyneaux PL. Respiratory microbiome and epithelial interactions shape immunity in the lungs. Immunology. 2020
  9. 160(2):171-182. [CrossRef] 9. Brandtzaeg P. Secretory IgA: Designed for anti-microbial defense. Front Immunol. 2013
  10. [CrossRef] 10. Burnett D. Immunoglobulins in the lung. Thorax. 1986
  11. 41(5):337- 344. [CrossRef] 11. Marsh RA, Orange JS. Antibody deficiency testing for primary immunodeficiency: A practical review for the clinician. Ann Allergy Asthma Immunol. 2019
  12. 123(5):444-453. [CrossRef] 12. Soler-Palacín P, de Gracia J, González-Granado LI et al. Primary immunodeficiency diseases in lung disease: Warning signs, diagnosis and management. Respir Res. 2018
  13. 19(1):219. [CrossRef] 13. Lougaris V, Soresina A, Baronio M et al. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality. J Allergy Clin Immunol. 2020
  14. 6749(20):30330-30334. 14. Barton J, Barton C, Bertoli L. Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency. PLOS ONE. 2019
  15. 14(5):e0216940. [CrossRef] 15. Aytekin C, Tuygun N, Gokce S, Dogu F, Ikinciogullari A. Selective IgA deficiency: Clinical and laboratory features of 118 children in Turkey. J Clin Immunol. 2012
  16. 32(5):961-966. [CrossRef] 16. Verma N,